4.6 Article

Measuring cystic fibrosis drug responses in organoids derived from 2D differentiated nasal epithelia

Journal

LIFE SCIENCE ALLIANCE
Volume 5, Issue 12, Pages -

Publisher

LIFE SCIENCE ALLIANCE LLC
DOI: 10.26508/lsa.202101320

Keywords

-

Categories

Funding

  1. Dutch Cystic Fibrosis Foundation (NCFS, HIT-CF grant)
  2. Netherlands Organization for Health Research and Development (ZonMw)
  3. Health Holland [40-41200-98-9296]
  4. CF Trust-UK [SRC 013]
  5. FCT/MCTES Portugal [UIDB/04046/2020, UIDP/04046/2020]
  6. EU [H2020-SC1-2017-755021]
  7. European Research Council (ERC) [819219]

Ask authors/readers for more resources

This study introduces an alternative method of culturing nasal-brushing-derived airway organoids, enabling consistent detection of CFTR modulator responses in patients with cystic fibrosis.
Cystic fibrosis is caused by genetic defects that impair the CFTR channel in airway epithelial cells. These defects may be overcome by specific CFTR modulating drugs, for which the efficacy can be predicted in a personalized manner using 3D nasal-brushing-derived airway organoids in a forskolin-induced swelling assay. Despite of this, previously described CFTR function assays in 3D airway organoids were not fully optimal, because of inefficient organoid differentiation and limited scalability. In this report, we therefore describe an alternative method of culturing nasal-brushing-derived airway organoids, which are created from an equally differentiated airway epithelial monolayer of a 2D air-liquid interface culture. In addition, we have defined organoid culture conditions, with the growth factor/cytokine combination neuregulin-1 beta and interleukin-1 beta, which enabled consistent detection of CFTR modulator responses in nasal-airway organoid cultures from subjects with cystic fibrosis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Pediatrics

Pediatric population with cystic fibrosis in the centre of Portugal: candidates for new therapies

Juliana Roda, Teresa Teixeira, Iris Ai Silva, Teresa Reis Silva, Ricardo Ferreira, Margarida D. Amaral, Guiomar Oliveira

Summary: This study characterized the clinical and genetic features of pediatric patients with CF in Portugal and identified candidates for CFTR modulator drugs. The results showed that the genetic and molecular characterization of CF is important for diagnosis, prognosis, and eligibility for treatment with CFTR modulator drugs.

JORNAL DE PEDIATRIA (2022)

Article Chemistry, Multidisciplinary

Unravelling Channel Structure-Diffusivity Relationships in Zeolite ZSM-5 at the Single-Molecule Level

Donglong Fu, J. J. Erik Maris, Katarina Stanciakova, Nikolaos Nikolopoulos, Onno van Der Heijden, Laurens D. B. Mandemaker, Marijn E. Siemons, Desiree Salas Pastene, Lukas C. Kapitein, Freddy T. Rabouw, Florian Meirer, Bert M. Weckhuysen

Summary: This study utilizes advanced techniques to track the diffusion of single molecules in zeolite materials, revealing different motion behaviors of guest molecules in different zeolite channels, with the geometry of the zeolite channels determining diffusion anisotropy. Additionally, the study shows that the addition of secondary pore networks primarily enhances the diffusivity of sinusoidal zeolite channels, alleviating diffusion limitations of microporous zeolites.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2022)

Article Biochemistry & Molecular Biology

Rare Trafficking CFTR Mutations Involve Distinct Cellular Retention Machineries and Require Different Rescuing Strategies

Sofia S. Ramalho, Iris A. L. Silva, Margarida D. Amaral, Carlos M. Farinha

Summary: This study characterized the defects associated with four rare CFTR variants and assessed their response to approved corrector drugs. The results showed that these variants belonged to Class II mutations and had different responses to the corrector drugs, highlighting the need for personalized drug discovery initiatives.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Cell Biology

Organization and dynamics of the cortical complexes controlling insulin secretion in β-cells

Ivar Noordstra, Cyntha M. van den Berg, Fransje W. J. Boot, Eugene A. Katrukha, Ka Lou Yu, Roderick P. Tas, Sybren Portegies, Bastiaan J. Viergever, Esther de Graaff, Casper C. Hoogenraad, Eelco J. P. de Koning, Francoise Carlotti, Lukas C. Kapitein, Anna Akhmanova

Summary: Insulin secretion in pancreatic beta-cells is regulated by cortical complexes that are enriched at the sites of adhesion to the extracellular matrix. Non-neuronal proteins LL5 beta and KANK1 are also present at insulin secretion sites and are involved in organizing exocytotic machinery. The dynamics of ELKS, an essential component of secretory complexes, is driven by binding and unbinding to low-mobility scaffolds, which are stimulated by glucose treatment. This study provides insights into the spatial organization of glucose-stimulated insulin release.

JOURNAL OF CELL SCIENCE (2022)

Article Cell Biology

Non-genomic steroid signaling through the mineralocorticoid receptor: Involvement of a membrane-associated receptor?

Henk Karst, Femke S. den Boon, Niek Vervoort, Max Adrian, Lukas C. Kapitein, Marian Joels

Summary: The mineralocorticoid receptor (MR) in the mammalian brain mediates both genomic and non-genomic actions, possibly located near or translocated to the cell membrane. Although it is challenging to convincingly visualize membrane localization of endogenous MR or GFP-MR molecules, there is evidence suggesting that MR may be trafficked via beta-arrestin.

MOLECULAR AND CELLULAR ENDOCRINOLOGY (2022)

Article Cell Biology

Rescue of Mutant CFTR Trafficking Defect by the Investigational Compound MCG1516A

Miqueias Lopes-Pacheco, Mafalda Bacalhau, Sofia S. Ramalho, Iris A. L. Silva, Filipa C. Ferreira, Graeme W. Carlile, David Y. Thomas, Carlos M. Farinha, John W. Hanrahan, Margarida D. Amaral

Summary: The study investigated the effects and mechanism of action of a newly developed F508del-CFTR corrector, MCG1516A, and found that it has additive effects to the FDA-approved corrector VX-661 in rescuing F508del-CFTR. Additionally, MCG1516A showed additive effects to genetic revertant R1070W, suggesting a potential binding site for this compound. This suggests that a combination of MCG1516A with other compounds could enhance correction of F508del-CFTR defects.

CELLS (2022)

Article Respiratory System

Development of novel therapeutics for all individuals with CF (the future goes on)

Margarida D. Amaral, Patrick T. Harrison

Summary: Despite advances in CF treatment, there is still a need to bring potentially curative therapies to all individuals with CF. This review discusses the missing aspects in treating all CF individuals and explores holistic approaches to identify drug targets and therapeutic approaches to correct the gene in its genome.

JOURNAL OF CYSTIC FIBROSIS (2023)

Review Neurosciences

Using the genome to correct the ion transport defect in cystic fibrosis

Margarida D. Amaral

Summary: Biomedicine is challenged to treat diseases by understanding their dysfunctional processes. Cystic fibrosis, as a monogenic disorder, has been extensively studied through 'omic' approaches to identify novel drug targets.

JOURNAL OF PHYSIOLOGY-LONDON (2023)

Article Pharmacology & Pharmacy

Identification of novel F508del-CFTR traffic correctors among triazole derivatives

Mafalda Bacalhau, Filipa C. Ferreira, Arthur Kmit, Felipe R. Souza, Veronica D. da Silva, Andre S. Pimentel, Margarida D. Amaral, Camilla D. Buarque, Miqueias Lopes-Pacheco

Summary: In this study, a collection of triazole compounds was screened to identify novel F508del-CFTR correctors. Four hit compounds, LSO-18, LSO-24, LSO-28, and LSO-39, were identified and shown to rescue F508del-CFTR processing, plasma membrane trafficking, and function. The mechanism of action of these compounds was investigated and it was found that LSO-18, LSO-24, and LSO-28 exhibited additive effects with the clinically approved drugs VX-661 and VX-445.

EUROPEAN JOURNAL OF PHARMACOLOGY (2023)

Review Pharmacology & Pharmacy

What Can RNA-Based Therapy Do for Monogenic Diseases?

Luka A. Clarke, Margarida D. Amaral

Summary: RNA-based approaches for treating monogenic diseases include the use of small antisense oligonucleotides and mRNA administration. However, further optimization is needed for these methods.

PHARMACEUTICS (2023)

Article Health Care Sciences & Services

Additive Potentiation of R334W-CFTR Function by Novel Small Molecules

Mafalda Bacalhau, Filipa C. Ferreira, Iris A. L. Silva, Camilla D. Buarque, Margarida D. Amaral, Miqueias Lopes-Pacheco

Summary: The authors generated a new CFBE cell line to screen a collection of compounds and identified new potentiators for R334W-CFTR. The active compounds were validated by electrophysiological assays and showed enhanced chloride secretion. The combination of these compounds with VX-770 further enhanced CFTR function.

JOURNAL OF PERSONALIZED MEDICINE (2023)

Review Cell Biology

Cellular cartography: Towards an atlas of the neuronal microtubule cytoskeleton

Malina K. Iwanski, Lukas C. Kapitein

Summary: Microtubules are essential for neuronal development and function, serving as tracks for intracellular transport and being involved in various neurodevelopmental and neurodegenerative disorders. The polar nature and composition of microtubules, including tubulin isotypes, post-translational modifications, associated proteins, stability, and orientation, play important roles in their function. Understanding these features and their effects on transport and organization in neurons is crucial.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2023)

Article Pediatrics

Airway Epithelial Cultures of Children with Esophageal Atresia as a Model to Study Respiratory Tract Disorders

Henriette H. M. Dreyer, Eleonora Sofie van Tuyll van Serooskerken, Lisa W. Rodenburg, Arnold J. N. Bittermann, Hubertus G. M. Arets, Ellen M. B. P. Reuling, Johannes W. Verweij, Eric G. Haarman, David C. van der Zee, Stefaan H. A. J. Tytgat, Cornelis K. van der Ent, Jeffrey M. Beekman, Gimano D. Amatngalim, Maud Y. A. Lindeboom

Summary: Esophageal atresia (EA) is a rare birth defect with respiratory disorders as a major cause of morbidity. This study aimed to evaluate the feasibility of culturing and characterizing motile cilia function in airway epithelial cell cultures and 3D organoids derived from EA patients. The results showed that EA patient-derived airway epithelial cultures and organoids displayed normal motile cilia function, suggesting their potential use in studying the role of epithelial function in respiratory disorders in EA.

CHILDREN-BASEL (2023)

No Data Available